Skip to main content
Equibles

Laird Norton Wetherby Trust Company, LLC

Bank

Position in INMB — Inmune Bio, Inc.

CIK 723204 Seattle, WA
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$84,760
+$28,260 QoQ
Shares Held
52,000
+4.0% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 83 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Derivatives in INMB

reported options exposure · as of Dec 31, 2023
CallValue
$112,600
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Laird Norton Wetherby Trust Company, LLC holds $18,816,907 across 20 Biotechnology names. INMB ranks #20 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,528 $5,726,302
2 ARGX
Argenx SE
 2,282 $2,117,170
3 ANIX
Anixa Biosciences Inc
 578,727 $1,620,435
4 REGN
Regeneron Pharmaceuticals, Inc.
 2,419 $1,508,342
5 RPRX
Royalty Pharma plc
 19,424 $1,089,102
6 ALNY
Alnylam Pharmaceuticals, Inc.
 3,300 $993,398
7 INCY
Incyte Corp
 7,051 $799,300
8 RVMD
Revolution Medicines, Inc.
 4,060 $760,356

All Filings in INMB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $84,760 52,000
2026-03-31 $56,500 50,000
2025-12-31 $70,200 45,000
2025-09-30 $51,750 25,000
2025-06-30 $85,470 37,000
2025-03-31 $285,846 36,600
2024-12-31 $159,247 34,100
2024-09-30 $177,061 32,850
2024-06-30 $277,830 31,500
2024-03-31 $370,125 31,500
2023-12-31 $112,600 10,000
2023-12-31 $354,690 31,500